When it comes to sexual intimacy, couples need to be more open with their partners about what satisfies them.
Given that the two of you share a special bond, there’s no reason for you to not be comfortable about discussing what you like – and don’t like about sex. After all, an activity that is meant to be enjoyed, should provide fulfillment for both parties.
As such, Menarini Philippines together with the Philippine Urological Association, boldly launched its Commit to Control PE Advocacy campaign last year to address one of the more pressing issues regarding sexual intimacy – premature ejaculation.
The campaign is meant to make couples more comfortable about discussing their intimacy concerns with each other, without it being a cause of insecurity or dissatisfaction.
This is because premature ejaculation can gravely affect one’s relationship when left undiscussed – and untreated.
In relation to this, Menarini Philippines held a talk, aptly called Happy Wife, Happy Life, which was held last January 10 at the Satin Room of the Seda Hotels in BGC and was attended by local bloggers. It aimed to shed better insight about what premature ejaculation is all about, and that it is not something to be embarrassed about because it can be controlled.
The event was hosted by popular celebrity columnist RJ Ledesma and featured a very insightful talk from sex and relationship guru, Dr. Margie Holmes, concerning “the love that last is better”.
Also present at the event was Dr. Dennis Serrano, who talked about the “basics” of premature ejaculation to help the guests have a better understanding of this condition.
Menarini Philippines strongly believes in this advocacy which is often left untreated because it is a topic that is usually considered taboo even in these modern times. The pharmaceutical giant hopes to make a stronger impact among Filipino couples on their campaign this year with more events like this.
About the Menarini Group
Menarini is the world’s largest Italian biopharmaceutical company with a heritage of over 128 years and over 16,000 employees in over 100 countries. Here in Asia-Pacific, Menarini’s vision is to be a leading provider of important healthcare brands to improve the lives of people in the region. Menarini Asia-Pacific operates across the entire commercial value chain, from regulatory approval and product launch to lifecycle management with a diverse portfolio of proprietary and partnered brands in key therapeutic fields, including Dermatology, Primary Care, Allergy/Respiratory, Cardiovascular, Select Specialty Care, Men’s Health and Consumer Health.
For further information, please visit: www.menariniapac.com.